Trade Vir Biotechnology VIR

Sell
 Buy

VirBiotechnology live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Jan 13, 22:38

Vir Biotechnology (NASDAQ:VIR) Trading 7.3% Higher - What's Next?

Vir Biotechnology Inc
Webhose 2026 Jan 13, 14:38

Vir Biotechnology (NASDAQ:VIR) Trading Up 7.3% - Should You Buy? - Daily Political

Vir Biotechnology Inc
Webhose 2026 Jan 08, 02:26

Vir Biotechnology (NASDAQ:VIR) Director Sells $130,460.00 in Stock - Daily Political

Vir Biotechnology Inc
Webhose 2026 Jan 05, 21:10

Company Website: https://vir.bio SAN FRANCISCO -- (Busines

Vir Biotechnology Inc
Webhose 2026 Jan 05, 20:45

Vicki Sato Sells 22,000 Shares of Vir Biotechnology (NASDAQ:VIR) Stock

Vir Biotechnology Inc
Webhose 2026 Jan 05, 00:00

Vir Biotechnology Inc. (VIR) - Insider Monkey

Vir Biotechnology Inc
Webhose 2026 Jan 03, 09:16

Brokerages Set Vir Biotechnology, Inc. (NASDAQ:VIR) Price Target at $17.30 - Markets Daily

Vir Biotechnology Inc
Webhose 2025 Dec 30, 18:36

Vir Biotechnology (NASDAQ:VIR) Stock Price Down 3.4% - Here's What Happened

Vir Biotechnology Inc
Webhose 2025 Dec 29, 10:44

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Rating of "Moderate Buy" by Brokerages

Vir Biotechnology Inc

VirBiotechnology News

Ghko B 2026 Jan 15, 16:00

Trending tech stock analysis: Is Super Micro (SMCI) a good stock to buy?

Ghko B 2026 Jan 15, 16:00

NIO stock price prediction 2026: NIO shares jump 1.8%, what’s next?

Ghko B 2026 Jan 15, 16:00

Best CFD trading platform full review: Is markets.com a legit CFD Broker?

Frances Wang 2026 Jan 15, 16:00

Trending cryptos price prediction: Bitcoin (BTC/USD), Ripple (XRP/USD), SOL

Frances Wang 2026 Jan 15, 16:00

CoreWeave stock price prediction: CRWV rises 5.8% today, what’s next?

Frances Wang 2026 Jan 14, 16:00

Forex market analysis: EUR/USD slides, GBP/USD down, USD/JPY rises

Frances Wang 2026 Jan 14, 16:00

Gold and Silver price forecast: Where will XAUUSD, XAGUSD go in 2026?

Ghko B 2026 Jan 14, 16:00

Super Micro (SMCI) Stock: What is the stock price forecast for SMCI 2026?

Ghko B 2026 Jan 13, 16:00

FTSE 100 Index hits new highs: What is the FTSE 100 prediction for 2026?

Ghko B 2026 Jan 12, 16:00

Ethereum price prediction 2026: What’s driving Ethereum’s value (ETH/USD)?

Latest news

Show more
Noah Lee 2025 Dec 06, 17:50

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee 2025 Dec 06, 17:00

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Liam James 2025 Dec 06, 12:40

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Ava Grace 2025 Dec 06, 11:50

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Noah Lee 2025 Dec 06, 10:50

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Emma Rose 2025 Dec 06, 09:40

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Ava Grace 2025 Dec 06, 09:30

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Sophia Claire 2025 Dec 06, 08:00

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift

Info

Spread

0.05

Spread (%)

0.8306 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

14:31 - 20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

843097664

Shares Outstanding

139125032

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.62

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2026 Jan 14, 16:00

Beginner's guide to CFD trading: How to trade CFDs in six steps?

Ghko B 2026 Jan 13, 16:00

What is FTSE 100 Index: How to trade FTSE 100 Index CFDs with markets.com?

Ghko B 2026 Jan 13, 16:00

Moving average indicator: What is the best indicator for moving average?

Trustpilot